INTELLIGENT BIO SOLUTIONS INC. current report, 31 August 2022

Business Context and Reporting Period

This Form 8-K is a current report filed by GBS Inc. (trading symbol: GBS) on August 31, 2022. The filing serves to announce the financial results for the three months and the full fiscal year ended June 30, 2022. The company is incorporated in Delaware and lists its common stock on the NASDAQ Capital Market. The registrant is classified as an emerging growth company.

Key Financial Metrics

The provided text is a cover sheet and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text.

Material Changes

The filing text does not provide specific details on material changes versus prior periods. It only confirms that results for the three months and full fiscal year ended June 30, 2022, were announced via a press release.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The report explicitly states that the information contained herein and in the accompanying exhibits shall not be incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Verify the specific revenue and net income figures for the quarter and fiscal year ended June 30, 2022, by reviewing Exhibit 99.1 (Press Release) referenced in this filing.
  • Confirm the company's current cash position and liquidity status, as these are not detailed in the 8-K cover sheet.
  • Review the full press release for any updated guidance or strategic shifts mentioned by management.
  • Note that the registrant is an emerging growth company, which may impact financial reporting standards and disclosure requirements.